Regen Therapeutics PLC - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Regen Therapeutics PLC. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Regen Therapeutics PLC. The Group's principal activities are developing healthcare products both nutraceutical and ethical pharmaceuticals and conducting pharmacokinetic and pharmacodynamic research. Its operation focuses on the research and development of a drug product called Colostrinin for the treatment for Alzheimer's disease and other neurological disorders. Colostrinin is a proline-rich polypeptide complex derived from ovine and bovine colostrum. The Group operates solely in the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report